L3T3 (Lansoprazole delayed release 15 mg)
Pill imprint L3T3 has been identified as Lansoprazole delayed release 15 mg.
Lansoprazole is used in the treatment of barrett's esophagus; erosive esophagitis; gerd; helicobacter pylori infection; duodenal ulcer (and more), and belongs to the drug class proton pump inhibitors. There is no proven risk in humans during pregnancy. Lansoprazole 15 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for L3T3 (Lansoprazole delayed release 15 mg)
More about lansoprazole
- Lansoprazole delayed-release capsules
- Lansoprazole orally disintegrating tablets
- Lansoprazole powder packet
- Lansoprazole (Advanced Reading)